NO992980L - Nitroimidazol gelpreparat - Google Patents

Nitroimidazol gelpreparat

Info

Publication number
NO992980L
NO992980L NO992980A NO992980A NO992980L NO 992980 L NO992980 L NO 992980L NO 992980 A NO992980 A NO 992980A NO 992980 A NO992980 A NO 992980A NO 992980 L NO992980 L NO 992980L
Authority
NO
Norway
Prior art keywords
nitroimidazole
gel preparation
water
skin
bydroxyalkyl
Prior art date
Application number
NO992980A
Other languages
English (en)
Norwegian (no)
Other versions
NO992980D0 (no
Inventor
Michael Goodman
Ke Lindahl
Original Assignee
Bioglan Ireland R & D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10804765&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO992980(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bioglan Ireland R & D Ltd filed Critical Bioglan Ireland R & D Ltd
Publication of NO992980D0 publication Critical patent/NO992980D0/no
Publication of NO992980L publication Critical patent/NO992980L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
NO992980A 1996-12-20 1999-06-17 Nitroimidazol gelpreparat NO992980L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9626513.7A GB9626513D0 (en) 1996-12-20 1996-12-20 A pharmaceutical composition
PCT/GB1997/003512 WO1998027960A2 (en) 1996-12-20 1997-12-19 A nitroimidazole gel composition

Publications (2)

Publication Number Publication Date
NO992980D0 NO992980D0 (no) 1999-06-17
NO992980L true NO992980L (no) 1999-08-16

Family

ID=10804765

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992980A NO992980L (no) 1996-12-20 1999-06-17 Nitroimidazol gelpreparat

Country Status (17)

Country Link
US (1) US6348203B1 (de)
EP (1) EP0946143B1 (de)
JP (1) JP2001507018A (de)
KR (1) KR20000069606A (de)
AT (1) ATE323466T1 (de)
AU (1) AU730812B2 (de)
CA (1) CA2275429A1 (de)
DE (1) DE69736998T2 (de)
DK (1) DK0946143T3 (de)
ES (1) ES2263183T3 (de)
GB (1) GB9626513D0 (de)
IE (1) IES80590B2 (de)
NO (1) NO992980L (de)
NZ (1) NZ336258A (de)
PT (1) PT946143E (de)
WO (1) WO1998027960A2 (de)
ZA (1) ZA9711455B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2232855C (en) 1997-04-10 2007-10-09 Roche Consumer Health (Worldwide) Sa Pharmaceutical formulation
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
EP1206937B1 (de) * 1999-07-16 2008-01-23 Shoei Co., Ltd. Nitroimidazolpräparationen zur äusseren anwendung zur behandlung von atopischer dermatitis
JP2002212073A (ja) * 2001-01-15 2002-07-31 Shoei:Kk 水性液剤
SE0103528D0 (sv) 2001-10-21 2001-10-21 Jan Faergeman Topiska kompositioner med förstärkt effekt
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
SE0301862D0 (sv) * 2003-06-26 2003-06-26 Jan Faergeman Sätt att inhibera tillväxten av mot antibiotika resistenta bakterier
US7456207B2 (en) * 2003-09-25 2008-11-25 Teva Pharmaceuticals Usa, Inc. Vaginal pharmaceutical compositions and methods for preparing them
FR2866569B1 (fr) * 2004-02-20 2007-08-24 Galderma Res & Dev Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter des pathologies liees au recepteur de type b de l'interleukine 8 et/ou au recepteur de type 1 de pacap
FR2866568B1 (fr) * 2004-02-20 2007-08-24 Galderma Res & Dev Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter un desordre de la vascularisation cutanee
FR2866570B1 (fr) * 2004-02-20 2007-08-24 Galderma Res & Dev Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter une inflammation cutanee
US20060093675A1 (en) * 2004-10-29 2006-05-04 Mathew Ebmeier Intravaginal treatment of vaginal infections with metronidazole compositions
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
MX2008014870A (es) 2006-05-30 2009-02-12 Intarcia Therapeutics Inc Modulador de flujo para sistema de suministro osmotico con canal interno de dos piezas.
EP3421031A1 (de) 2006-08-09 2019-01-02 Intarcia Therapeutics, Inc Osmotisches verabreichungssystem mit kolbenanordnung
US8258164B2 (en) * 2006-09-12 2012-09-04 Curatek Pharmaceuticals Holding, Inc. Nitroimidazole composition and method
JP5238295B2 (ja) * 2007-03-09 2013-07-17 第一三共ヘルスケア株式会社 低刺激性透明半固形外用剤
CN101715340A (zh) 2007-04-23 2010-05-26 精达制药公司 促胰岛素释放肽的混悬制剂及其应用
DE102008006394A1 (de) * 2008-01-28 2009-07-30 Beiersdorf Ag Verwendung von Wirkstoffkomplexen aus Panthenol, Glycerin, Citrat und/oder Bisabolol gegen Pollenallergien
EP2240155B1 (de) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe
US20100105750A1 (en) * 2008-10-23 2010-04-29 Nycomed Us Inc. Stable metronidazole gel formulations
SI2462246T1 (en) 2009-09-28 2018-01-31 Intarcia Therapeutics, Inc. Fast-setting and / or cessation of substantially unchanged delivery of the product
US9700650B2 (en) 2009-11-09 2017-07-11 Spotlight Technology Partners Llc Polysaccharide based hydrogels
US8795727B2 (en) 2009-11-09 2014-08-05 Spotlight Technology Partners Llc Fragmented hydrogels
JP5881698B2 (ja) * 2010-07-19 2016-03-09 ブラセルズ ベンチャーズ コーポレーションＢｒｕｓｅｌｌｓ Ｖｅｎｔｕｒｅｓ Ｃｏｒｐ． エーテルヒドロキシエチルセルロースを含む抗微生物医療用ジェル
JP5954928B2 (ja) * 2010-11-19 2016-07-20 大同化成工業株式会社 皮膚潰瘍処置用外用剤のゲル状基剤
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
MX2014000066A (es) 2011-06-28 2014-05-01 Medicis Pharmaceutical Corp Formulaciones mucoadhesivas en gel de alta dosificación de metronidazol de base acuosa y su uso para tratar la vaginosis bacteriana.
US20140206735A1 (en) * 2012-12-20 2014-07-24 Medicis Pharmaceutical Corporation High dosage topical metronidazole aqueous-based gel formulations and their use to treat rosacea
EP3013368A1 (de) 2013-06-25 2016-05-04 Mission Pharmacal Company Neuartige formulierungen zur behandlung von vaginalen erkrankungen
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
KR102650751B1 (ko) 2015-06-03 2024-03-22 인타르시아 세라퓨틱스 인코포레이티드 임플란트 배치 및 제거 시스템들
CN107847604B (zh) * 2015-10-25 2020-11-10 艾威药业(珠海)有限公司 眼用原位凝胶处方
SG10201913699QA (en) 2016-05-16 2020-03-30 Intarcia Therapeutics Inc Glucagon-receptor selective polypeptides and methods of use thereof
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
AU2018206539A1 (en) 2017-01-03 2019-07-18 Intarcia Therapeutics, Inc. Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421443C2 (de) * 1984-06-08 1996-09-05 Daicel Chem Stabile Gelmasse und Verfahren zu ihrer Herstellung
US5536743A (en) * 1988-01-15 1996-07-16 Curatek Pharmaceuticals Limited Partnership Intravaginal treatment of vaginal infections with buffered metronidazole compositions
EP0386960A3 (de) * 1989-03-07 1991-10-23 American Cyanamid Company Pharmazeutische Zusammensetzungen zur Verwendung als Wirkstoffabgabevehikel und/oder als Wundverband
GB2229443A (en) * 1989-03-07 1990-09-26 American Cyanamid Co Wound dressings
CA1337279C (en) * 1989-06-06 1995-10-10 Robert J. Borgman Intravaginal treatment of vaginal infections with buffered metronidazole compositions
DK0564586T3 (da) * 1990-12-21 2002-07-15 Felice Bombart Vandige vaginaludskylninger og beslægtede fremgangsmåder
US5662924A (en) * 1991-03-21 1997-09-02 Smith & Nephew Plc Wound dressing
GB9105995D0 (en) * 1991-03-21 1991-05-08 Smith & Nephew Wound dressing
SE506509C2 (sv) * 1992-04-14 1997-12-22 Bioglan Ab Användning av imidazoler för framställning av en farmaceutisk formulering för behandling av inflammatoriska och/eller infektiösa hudsjukdomar
US5391367A (en) * 1993-07-28 1995-02-21 Pfizer Inc. Antifungal nail solution

Also Published As

Publication number Publication date
IES970906A2 (en) 1998-10-07
AU5330898A (en) 1998-07-17
WO1998027960A3 (en) 1998-09-11
AU730812B2 (en) 2001-03-15
PT946143E (pt) 2006-08-31
ZA9711455B (en) 1998-09-02
DE69736998T2 (de) 2007-03-01
EP0946143A2 (de) 1999-10-06
WO1998027960A2 (en) 1998-07-02
JP2001507018A (ja) 2001-05-29
NZ336258A (en) 2001-04-27
IES80590B2 (en) 1998-10-07
GB9626513D0 (en) 1997-02-05
NO992980D0 (no) 1999-06-17
KR20000069606A (ko) 2000-11-25
DK0946143T3 (da) 2006-08-21
US6348203B1 (en) 2002-02-19
CA2275429A1 (en) 1998-07-02
ATE323466T1 (de) 2006-05-15
ES2263183T3 (es) 2006-12-01
EP0946143B1 (de) 2006-04-19
DE69736998D1 (de) 2007-01-04

Similar Documents

Publication Publication Date Title
NO992980L (no) Nitroimidazol gelpreparat
AR002944A1 (es) Uso de una composicion de gel acuosa que contiene una o mas drogas que son eficaces para tratar hemorroides para la preparacion de un medicamento y dicha composicion de gel acuosa
ATE163863T1 (de) Gelwundverbandszusammensetzungen und verfahren zu deren gebrauch
ATE274900T1 (de) Stabilgelmischung in form einer mischung eines öligen gels und eines wässrigen gels
DE69617723D1 (de) Wachsumsfaktoren enthaltende gelformulierungen
UA41989C2 (uk) Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
EP0640647A3 (de) Ionisch vernetzte Gele aus Glykosaminoglykan zur Vermehrung von Weichgewebe und Arzneimittelabgabe.
AU2002342765A1 (en) Active ingredient combinations of polyhexamethylenebiguanidine hydrochloride and distearyldimethylammonium chloride and preparations comprising said active ingredient combinations
DE60103894D1 (de) Sprühfähige wundversorgungszusammensetzung
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
FR2542616B1 (fr) Composition pour le traitement des muqueuses a base d'un antibiotique et d'un hydrocolloide formateur de gel
DE60002719T2 (de) Ophthalmische zusammensetzungen in form wässriger gele
ES2176495T3 (es) Utilizacion de un antagonista de la bradiquinina, destinada a inducir y/o estimular el crecimiento de los cabellos y/o frenar su caida.
BR9903751A (pt) Composição para uso cosmético e/ou dermatológico, utilização cosmética da composição, utilização da composição e utilização de pelo menos um ácido aminossulfÈnico n-substituìdo
FR2719475B1 (fr) Composition cosmétique et/ou dermatologique à gélifiant polymérique cationique, ses utilisations notamment pour la dépigmentation de la peau.
PT1140001E (pt) Composicao para tratamento de queimaduras
AR017170A1 (es) Composicion oftalmologica
IT9048186A0 (it) Impiego teperautico della ranitidina nella cura di ferite interessantila cute e i tessuti sottostanti
GT199600070A (es) Composicion de gel cosmetica teniendo irritacion de la piel reducida.
TH9143EX (th) ส่วนประกอบของเจบทาแผลและวิธีการใช้
ES281238U (es) Parche antiarrugas y-o para los cuidados de la piel

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application